ライフサイエンスコーパス: cyanocobalamin

1 f radioactive isotopes like [57Co]- or [14C]-cyanocobalamin.

2 tive decyanation reaction when it encounters cyanocobalamin.

3 , ferritin, from a small biological organic, cyanocobalamin.

4 ication of the corrin ring b-propionamide of cyanocobalamin.

5 respectively, than transcobalamin binding to cyanocobalamin.

6 ding capacity assay and compared to DTPA and cyanocobalamin.

7 the transcobalamin proteins when compared to cyanocobalamin.

8 ot the pdu) operon is repressed by exogenous cyanocobalamin.

9 lcobalamins and the reductive decyanation of cyanocobalamin.

10 cted for valproic acid, isovaleric acid, and cyanocobalamin.

11 de, to transform all forms of cobalamin into cyanocobalamin.

12 ew method is demonstrated in the analysis of cyanocobalamin, a vitamin B12 supplement, and of an eye-

13 In cobalamin deficiency, 2 mg of cyanocobalamin administered orally on a daily basis was

14 Cyanocobalamin, also known as Vitamin B(12), possesses n

15 ystal structures of human HC in complex with cyanocobalamin and cobinamide at 2.35 and 3.0 A resoluti

16 odamine) and pharmaceutical compounds (e.g., cyanocobalamin and folic acid).

17 consists of 1 mg of folic acid and 0.5 mg of cyanocobalamin and the diet that includes grains fortifi

18 protein required for high-affinity uptake of cyanocobalamin and the translocation of E group colicins

19 s performed for measurement of homocysteine, cyanocobalamin, and erythrocyte folate in participants o

20 ridoxine HCl; 50 microg each of d-biotin and cyanocobalamin; and 400 mcg of folate) or placebo for 30

21 g folic acid, 7.2 mg pyridoxine, and 0.02 mg cyanocobalamin), antioxidant vitamins alone (150 mg asco

22 osed cobalamin deficient patients to receive cyanocobalamin as either 1 mg intramuscularly on days 1,

23 Participants were treated with oral cyanocobalamin at a dosage of 1000 mug/d throughout the

24 Methyl-, adenosyl- and cyanocobalamin-b-(4-aminobutyl)-amide-DTPA analogs and D

25 Methyl-, adenosyl- and cyanocobalamin-b-(4-aminobutyl)-amide-DTPA analogs were

26 Cyanocobalamin-b-(5-aminopentylamide) was immobilized on

27 Transcobalamin binds cyanocobalamin-b-(5-aminopentylamide) with association a

28 Cyanocobalamin (B12) functions as the biocompatible wate

29 Response data for cyanocobalamin binding to the transcobalamin protein sur

30 Exogenously added transcobalamin II-[57Co]cyanocobalamin bound very poorly (2-5%) to the affected

31 cobalt containing compounds, namely Co(II), cyanocobalamin (CN-Cbl) and hydroxylcobalamin (OH-Cbl),

32 In the presence of calcium, cyanocobalamin (CN-Cbl) displaces E-peptide-1 with a nan

33 plicated calcium in high-affinity binding of cyanocobalamin (CN-Cbl) to BtuB.

34 showed that of the four Co(III) derivatives (cyanocobalamin [CN-Cbl], aquocobalamin [H2O-Cbl], adenos

35 ter-membrane transporter for vitamin B12 (or cyanocobalamin, CN-Cbl) in Escherichia coli.

36 racterize the photochemistry of vitamin B12, cyanocobalamin (CNCbl), in solution.

37 ependent reductive decyanation activity with cyanocobalamin (CNCbl).

38 B-dependent active transport of vitamin B12 [cyanocobalamin (CNCbl)] across the outer membrane of Esc

39 aimed to investigate the stability of added cyanocobalamin (CNCbl, chemically modified form) and hyd

40 e excited-state photophysics of vitamin B12 (cyanocobalamin, CNCbl) and the related cob(III)alamins,

41 acobalamin (H(2)OCbl(+)), and vitamin B(12) (cyanocobalamin, CNCbl).

42 ith tandem mass spectrometry (LC-MS/MS), the cyanocobalamin content was determined as 0.42 +/- 0.09 m

43 o 1 of 3 dosage groups: 0, 25, or 100 microg cyanocobalamin/d.

44 ermination of 5'-hydroxy-alpha-ribofuranosyl cyanocobalamin derivatives with solely 1-D (13)C and DEP

45 of how the cyanide group in vitamin B(12) or cyanocobalamin, discovered 60 years ago, is removed, has

46 The same analysis for the negative control, cyanocobalamin, found no association with suicide attemp

47 Oral supplementation with 1000 mug/d of cyanocobalamin has been shown to improve vitamin B12 def

48 ive forms of vitamin B12 (adenosylcobalamin, cyanocobalamin, hydroxocobalamin, methylcobalamin) from

49 The structure of cyanocobalamin in DMSO-d(6) has been assigned using COSY

50 was to measure the bioavailability of [13C]-cyanocobalamin in humans and to assess the effect of par

51 ive method for the detection of vitamin B12 (cyanocobalamin) is presented.

52 Here, we present several prototypes of Cyanocobalamin-loaded Dissolving Microarray Patches (B(1

53 It has four bioactive forms: cyanocobalamin, methylcobalamin, hydroxocobalamin and 5'

54 ut not decyanation activity, suggesting that cyanocobalamin might be therapeutically useful for patie

55 be rescued by the addition of vitamin B(12) (cyanocobalamin) or the lower ligand of cobalamin, 5,6-di

56 patients with known CHD with folic acid and cyanocobalamin over a 10-year period would result in 310

57 ted nanoparticles loaded with pyridoxine and cyanocobalamin (PC-PP NPs).

58 ctivities for processing alkylcobalamins and cyanocobalamin, respectively, to a common intermediate t

59 Folic acid and cyanocobalamin supplementation may be cost-effective amo

60 lved in assimilatory sulphate reduction, and cyanocobalamin synthesis.

61 ve elevated serum MMA were treated with oral cyanocobalamin tablets (1000 microg/d) for 3 mo.

62 Unlike cyanocobalamin transport through the outer membrane, FeE

63 a stable isotope-labeled vitamin B-12, [13C]-cyanocobalamin, using Salmonella enterica by providing [

64 ity, catalyzing the reductive decyanation of cyanocobalamin (vitamin B(12)), and the dealkylation of

65 and its nutritional determinants folate and cyanocobalamin (vitamin B-12) have been shown to affect

66 Co could also be separated from Co bound to cyanocobalamin (vitamin B-12).

67 xine hydrochloride (vitamin B6), and 2 mg of cyanocobalamin (vitamin B12) or a placebo.

68 l compounds such as pyridoxine (vitamin B6), cyanocobalamin (vitamin B12), and apigenin (a plant flav

69 ysis was repeated with a control supplement (cyanocobalamin, vitamin B12).

70 [13C]-cyanocobalamin was completely decyanated to [13C]-methyl

71 of new force-field parameters developed for cyanocobalamin, we also simulated the substrate-bound fo

72 mocysteine, red blood cell folate, and serum cyanocobalamin were unrelated to ARM in the overall samp

73 % of total B vitamins); B8 (biotin) and B12 (cyanocobalamin) were not detected in lentil samples.

74 btuB RNA was inhibited by Ado-Cbl but not by cyanocobalamin, with half-maximal inhibition around 0.3